Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Lewis

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Nature. Mental Health|April 10, 2023
Predicting treatment resistance from first-episode psychosis using routinely collected clinical informationEmanuele F Osimo, Benjamin I Perry, Pavan Mallikarjun, et al.
Cancer Investigation|April 26, 2021
Radiation Therapy for Primary Cutaneous Gamma Delta Lymphoma Prior to Stem Cell TransplantationYufan F Wu, Lawrie Skinner, Jonathan Lewis, et al.
Nutrients|May 13, 2026
The Effect of β-Hydroxy-β-Methyl Butyrate (HMB) upon Acute Fed-State Muscle Protein Turnover in Older Men and Women: A Randomized Double-Blind Controlled Crossover Clinical TrialKenneth Smith, Haitham Abdullah, Supreeth Rudrappa, et al.
Investigational New Drugs|July 1, 2009
Phase II study of darinaparsin in patients with advanced hepatocellular carcinomaJennifer Wu, Charles Henderson, Lynn Feun, et al.
The Lancet. Infectious Diseases|May 9, 2026
Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trialNatasha Thorn, Zsofia Danos, Nick J Andrews, et al.
Communications Biology|October 11, 2024
Type-H endothelial cell protein Clec14a orchestrates osteoblast activity during trabecular bone formation and patterningGeorgiana Neag, Jonathan Lewis, Jason D Turner, et al.
Transboundary and Emerging Diseases|January 26, 2026
Detection of Two High Pathogenicity Avian Influenza Virus (HPAIV) Subtypes, H5N1 and H5N5, in a Mass Mortality Event in Wild Seabirds and Co-Location With Dead SealsMarco Falchieri, Eleanor Bentley, Holly A Coombes, et al.
BMC Geriatrics|July 8, 2025
Protocol for the REBOUND study: a cohort study to uncover fundamental mechanisms of accelerated ageing and impaired resilience following cancer surgery and treatmentCarly Welch, Animesh Acharjee, Rebecca Birch, et al.
BMJ Open|May 27, 2021
Changes in daily mental health service use and mortality at the commencement and lifting of COVID-19 'lockdown' policy in 10 UK sites: a regression discontinuity in time designIoannis Bakolis, Robert Stewart, David Baldwin, et al.
Journal of Medicinal Chemistry|July 29, 2010
Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug designAndrew J Woodhead, Hayley Angove, Maria G Carr, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Nature. Mental Health|April 10, 2023
Predicting treatment resistance from first-episode psychosis using routinely collected clinical informationEmanuele F Osimo, Benjamin I Perry, Pavan Mallikarjun, et al.
Cancer Investigation|April 26, 2021
Radiation Therapy for Primary Cutaneous Gamma Delta Lymphoma Prior to Stem Cell TransplantationYufan F Wu, Lawrie Skinner, Jonathan Lewis, et al.
Nutrients|May 13, 2026
The Effect of β-Hydroxy-β-Methyl Butyrate (HMB) upon Acute Fed-State Muscle Protein Turnover in Older Men and Women: A Randomized Double-Blind Controlled Crossover Clinical TrialKenneth Smith, Haitham Abdullah, Supreeth Rudrappa, et al.
Investigational New Drugs|July 1, 2009
Phase II study of darinaparsin in patients with advanced hepatocellular carcinomaJennifer Wu, Charles Henderson, Lynn Feun, et al.
The Lancet. Infectious Diseases|May 9, 2026
Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trialNatasha Thorn, Zsofia Danos, Nick J Andrews, et al.
Communications Biology|October 11, 2024
Type-H endothelial cell protein Clec14a orchestrates osteoblast activity during trabecular bone formation and patterningGeorgiana Neag, Jonathan Lewis, Jason D Turner, et al.
Transboundary and Emerging Diseases|January 26, 2026
Detection of Two High Pathogenicity Avian Influenza Virus (HPAIV) Subtypes, H5N1 and H5N5, in a Mass Mortality Event in Wild Seabirds and Co-Location With Dead SealsMarco Falchieri, Eleanor Bentley, Holly A Coombes, et al.
BMC Geriatrics|July 8, 2025
Protocol for the REBOUND study: a cohort study to uncover fundamental mechanisms of accelerated ageing and impaired resilience following cancer surgery and treatmentCarly Welch, Animesh Acharjee, Rebecca Birch, et al.
BMJ Open|May 27, 2021
Changes in daily mental health service use and mortality at the commencement and lifting of COVID-19 'lockdown' policy in 10 UK sites: a regression discontinuity in time designIoannis Bakolis, Robert Stewart, David Baldwin, et al.
Journal of Medicinal Chemistry|July 29, 2010
Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug designAndrew J Woodhead, Hayley Angove, Maria G Carr, et al.
Pageof 9